Remdesivir is Effective for Moderately Severe Patients: A Re-Analysis of the First Double-Blind, Placebo-Controlled, Randomized Trial on Remdesivir for Treatment of Severe COVID-19 Patients Conducted in Wuhan City
Shih, Weichung J, Shen, Xin, Zhang, Peng, Xie, TaiVolume:
Volume 12
Journal:
Open Access Journal of Clinical Trials
DOI:
10.2147/OAJCT.S262606
Date:
July, 2020
File:
PDF, 335 KB
2020